Mapping genetic determinants for human immunodeficiency virus type 1 resistance to soluble CD4

J Virol. 1992 May;66(5):3125-30. doi: 10.1128/JVI.66.5.3125-3130.1992.

Abstract

Neutralization of human immunodeficiency virus type 1 (HIV-1) infection with soluble CD4 (sCD4) can be achieved over a broad range of concentrations for different virus strains. Laboratory virus strains passaged in transformed T-cell lines are typically sensitive to sCD4 neutralization, whereas primary virus isolates require over 100-fold-higher sCD4 concentrations. Using recombinant viruses generated from a laboratory strain, HIV-1NL4-3, and a primary macrophagetropic strain, HIV-1JR-FL, we mapped a region of gp120 important for determining sensitivity to sCD4 neutralization. This same region has previously been defined as important for macrophage and transformed T-cell line tropism and includes the V3 neutralization domain but does not include regions of gp120 that have been shown to be most important for CD4 binding.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Acquired Immunodeficiency Syndrome / genetics*
  • Acquired Immunodeficiency Syndrome / prevention & control
  • Antigen-Antibody Reactions
  • Binding Sites
  • CD4 Antigens / metabolism*
  • Chromosome Mapping
  • Cloning, Molecular
  • Epitopes / genetics*
  • Epitopes / metabolism
  • HIV Envelope Protein gp120 / genetics*
  • HIV Envelope Protein gp120 / metabolism
  • HIV-1 / genetics*
  • HIV-1 / pathogenicity
  • Humans
  • Organ Specificity
  • Polymerase Chain Reaction
  • Recombination, Genetic

Substances

  • CD4 Antigens
  • Epitopes
  • HIV Envelope Protein gp120